In one paragraphArticle in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Marta Fenoll-MoranteCarVasCare Research Group, Instituto de Biomedicina, Facultad de Enfermería de Cuenca, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.ORCID 0009-0009-5164-5187 Alicia Saz-LaraCarVasCare Research Group, Instituto de Biomedicina, Facultad de Enfermería de Cuenca, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.ORCID 0000-0003-0669-8625 Arturo Martinez-RodrigoResearch Group in Medical Informatics, E-Health and Advances Technologies, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.ORCID 0000-0003-2343-3186 Nerea Moreno-HerraizCarVasCare Research Group, Instituto de Biomedicina, Facultad de Enfermería de Cuenca, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.ORCID 0009-0007-5385-1406 Iris Otero-LuisCarVasCare Research Group, Instituto de Biomedicina, Facultad de Enfermería de Cuenca, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.ORCID 0009-0005-3784-9926 José Alberto Martínez-HortelanoFaculty of Nursing, Universidad de Castilla-La Mancha, 02006 Albacete, Spain.
Carla Geovanna Lever-MeginaCarVasCare Research Group, Instituto de Biomedicina, Facultad de Enfermería de Cuenca, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.
Iván Cavero-RedondoCarVasCare Research Group, Instituto de Biomedicina, Facultad de Enfermería de Cuenca, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.ORCID 0000-0003-2617-0430 Funding
Carvascare Research Group from the Universidad de Castilla-La Mancha 2025-GRIN-38419COMETA Research Group from the Universidad de Castilla-La Mancha 2025-GRIN-38292Instituto de las Mujeres MUJER-EVA study, 35-6-ID24Junta de Comunidades de Castilla-La Mancha and European Regional Development Fund (EU) SBPLY/24/180225/000046
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
advanced glycation and productsaortic pulse wave velocitycardiovascular diseaseearly vascular agingglycated hemoglobin and pulse pressure
Identifiers
PMID42513434
PMCPMC13412954
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390